Scarica l'app Stockscreener
3.35
7.54%
0.235
Pre-mercato:
3.52
0.17
+5.07%
Precedente Chiudi:
$3.115
Aprire:
$3.11
Volume 24 ore:
38,168
Relative Volume:
1.09
Capitalizzazione di mercato:
$98.64M
Reddito:
-
Utile/perdita netta:
$-1.77M
Rapporto P/E:
-22.53
EPS:
-0.1487
Flusso di cassa netto:
$-1.46M
1 W Prestazione:
-1.47%
1M Prestazione:
-8.47%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$3.01
$3.35
Intervallo di 1 settimana:
$3.01
$3.58
Portata 52W:
$2.5701
$26.50
Turn Therapeutics Inc Stock (TTRX) Company Profile
Nome
Turn Therapeutics Inc
Settore
Industria
Telefono
(818) 564-4011
Indirizzo
250 NORTH WESTLAKE BLVD., WESTLAKE VILLAGE
Compare TTRX vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TTRX
Turn Therapeutics Inc
|
3.35 | 98.64M | 0 | -1.77M | -1.46M | -0.1487 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Turn Therapeutics Inc Stock (TTRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-29 | Iniziato | D. Boral Capital | Buy |
Turn Therapeutics Inc Borsa (TTRX) Ultime notizie
Head-To-Head Review: Athersys (NASDAQ:ATHX) versus Turn Therapeutics (NASDAQ:TTRX) - Defense World
Athersys and Turn Therapeutics Battle for Biotech Supremacy - National Today
Turn Therapeutics (TTRX) CEO-linked entity gifts 300,000 shares, retains 15.7M - stocktitan.net
Director at Turn Therapeutics (TTRX) makes bona fide gift of 300,000 shares - stocktitan.net
Turn Therapeutics (TTRX) CEO receives 160,000 stock options at $3.43 strike - stocktitan.net
80K options granted at $3.12 to Turn Therapeutics (TTRX) - stocktitan.net
[EFFECT] Turn Therapeutics Inc. SEC Filing - stocktitan.net
TTRX Stock Price, Quote & Chart | TURN THERAPEUTICS INC (NASDAQ:TTRX) - ChartMill
Turn Therapeutics (NASDAQ:TTRX) Issues Earnings Results - MarketBeat
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength? - Yahoo Finance
Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates - biospace.com
Turn Therapeutics (TTRX) registers up to 7,000,000 shares for GEM resale - stocktitan.net
Turn Therapeutics (TTRX) registers 17.87M shares for resale by stockholders - stocktitan.net
Turn Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Turn Therapeutics (TTRX) details eczema drug plans and going-concern risk - Stock Titan
Turn Therapeutics (NASDAQ: TTRX) widens 2025 loss but secures $25M growth capital - stocktitan.net
Turn Therapeutics Secures Up to $25 Million Financing from Avenue Capital to Advance Atopic Dermatitis and Onychomycosis Programs - Minichart
Turn Therapeutics secures up to $25M in financing from Avenue Capital Group - MSN
D. Boral Capital Reaffirms Buy Rating for Turn Therapeutics (NASDAQ:TTRX) - MarketBeat
TTRX Maintains 'Buy' Rating with $8.00 Price TargetLatest Ana - GuruFocus
Turn Therapeutics Secures Growth Capital to Advance Dermatology - tipranks.com
Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group - PharmiWeb.com
Turn Therapeutics Secures Up To $25 Million Term Loan Facility From Avenue Venture Opportunities - TradingView
Turn Therapeutics (Nasdaq: TTRX) secures up to $25M loan facility - Stock Titan
Turn Therapeutics Inc. Enters into Loan and Security Agreement for Up to $25 Million Growth Capital Loan Facility with Avenue Venture Opportunities Fund Ii, L.P - MarketScreener
Turn Therapeutics secures $25M loan facility from Avenue Capital By Investing.com - Investing.com Canada
Turn Therapeutics secures $25M loan facility from Avenue Capital - Investing.com
Turn Therapeutics, Inc. Secures Up to $25 Million in Financing from Avenue Capital Group - marketscreener.com
Turn Therapeutics Inc. announced that it expects to receive $25 million in funding from Avenue Capital Management II, L.P. - MarketScreener
Turn Therapeutics Inc. (TTRX) AI-Powered Stock Analysis - Meyka
Turn Therapeutics Inc. (TTRX) Stock forecasts - Yahoo Finance UK
Turn Therapeutics (TTRX) Stock Forecast and Price Target 2026 $TTRX - MarketBeat
Reviewing Bio-Path (NASDAQ:BPTH) & Turn Therapeutics (NASDAQ:TTRX) - Defense World
Turn Therapeutics (TTRX) Stock Analysis Report | Financials & Insights - Benzinga España
TTRX: Phase II eczema trial for a novel IL-36/IL-31 inhibitor expects key data in Q2 2026 - TradingView
Turn Therapeutics Talks GX-03 Phase II Eczema Data Timeline and Non-Systemic Topical Strategy - MarketBeat
TTRX: Lead topical for eczema in phase II, with phase III trials planned and strong safety data - TradingView
Atara jumps amid report on FDA’s U-turn on cell therapy - Seeking Alpha
Technical Analysis of Turn Therapeutics Inc. (NASDAQ:TTRX) - TradingView
Turn Therapeutics Appoints Robert Redfield as Senior Advisor - TipRanks
Turn appoints Dr. Robert Redfield as senior advisor to guide GX-03 regulatory and clinical strategy - TradingView
Former CDC director joins Turn Therapeutics (TTRX) as senior health policy advisor - Stock Titan
Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs - Caledonian Record
How much upside does Compass Therapeutics Inc. haveWall Street Watch & Daily Stock Momentum Reports - mfd.ru
What is the next catalyst for Palvella Therapeutics Inc.July 2025 Spike Watch & Consistent Return Investment Signals - mfd.ru
TTRX Should I Buy - Intellectia AI
Turn Therapeutics Inc.Common Stock (Nasdaq:TTRX) Stock Quote - FinancialContent
Will Ovid Therapeutics Inc. announce a stock splitQuarterly Market Review & Detailed Earnings Play Strategies - mfd.ru
Can Xilio Therapeutics Inc. expand into new marketsDollar Strength & Entry Point Confirmation Signals - mfd.ru
Aug Sentiment: What is the fair value of Candel Therapeutics Inc. stock nowJuly 2025 Reactions & Weekly Top Stock Performers List - mfd.ru
Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences - BioSpace
Turn Therapeutics Inc Azioni (TTRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):